These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21151895)

  • 1. Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.
    Ishiguro M; Mishiro K; Fujiwara Y; Chen H; Izuta H; Tsuruma K; Shimazawa M; Yoshimura S; Satoh M; Iwama T; Hara H
    PLoS One; 2010 Dec; 5(12):e15178. PubMed ID: 21151895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
    Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M
    Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives.
    Takagi T; Hara H
    J Pharmacol Sci; 2016 Jul; 131(3):155-61. PubMed ID: 27381422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol ameliorates warfarin-induced hemorrhagic transformation after cerebral ischemia in mice.
    Kitashoji A; Egashira Y; Mishiro K; Suzuki Y; Ito H; Tsuruma K; Shimazawa M; Hara H
    Stroke; 2013 Oct; 44(10):2862-8. PubMed ID: 23881959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
    Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
    Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death.
    Kim HN; Kim TY; Yoon YH; Koh JY
    Brain Res; 2015 Dec; 1628(Pt B):317-326. PubMed ID: 26111647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage.
    Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of phosphodiesterase-III protects against oxygen-glucose deprivation in endothelial cells by upregulation of VE-cadherin.
    Ishiguro M; Suzuki Y; Mishiro K; Kakino M; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Curr Neurovasc Res; 2011 May; 8(2):86-94. PubMed ID: 21443459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats.
    Kawamura K; Takahashi T; Kanazawa M; Igarashi H; Nakada T; Nishizawa M; Shimohata T
    PLoS One; 2014; 9(6):e98639. PubMed ID: 24896569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier.
    Takagi T; Imai T; Mishiro K; Ishisaka M; Tsujimoto M; Ito H; Nagashima K; Matsukawa H; Tsuruma K; Shimazawa M; Yoshimura S; Kozawa O; Iwama T; Hara H
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):123-139. PubMed ID: 26661252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries.
    Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ
    Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
    Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
    Neuroscience; 2012 Mar; 205():39-48. PubMed ID: 22244977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice.
    Chen S; Chen Z; Cui J; McCrary ML; Song H; Mobashery S; Chang M; Gu Z
    eNeuro; 2018; 5(3):. PubMed ID: 29963617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.
    Tang J; Li YJ; Li Q; Mu J; Yang DY; Xie P
    Neurol Res; 2010 Jun; 32(5):541-6. PubMed ID: 19309545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T; Lo EH
    Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.